What is more, we theorized that ZEB1-AS1 can modulate GC occurrence, progress, and metastasis through a ZEB1-AS1/miR-149-3p axis; a thought reinforced by the outcomes from related studies. The gene discussed is ZEB1; the disease is gastric cancer.